HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

EFF1009

a medical food that decreases leukotriene B(4) synthesis

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Lindemann, Julianne: 2 articles (12/2009 - 02/2008)
2.	Stull, Dean: 2 articles (12/2009 - 02/2008)
3.	Belofsky, Gil: 1 article (12/2009)
4.	David Pampe, E: 1 article (12/2009)
5.	Orozco-Cronin, Patti: 1 article (12/2009)
6.	Peterkin, Joanna J: 1 article (12/2009)
7.	Surette, Marc E: 1 article (02/2008)

Related Diseases

1.

Asthma (Bronchial Asthma)

12/01/2009 - "Two previous clinical studies with EFF1009 provided preliminary evidence that the medical food improves asthma-related quality of life (ARQOL) and asthma management. "
12/01/2009 - "The dietary addition of the medical food EFF1009 to asthma management regimens can improve patient perceived, ARQOL and can also improve asthma management as evidenced by reduced asthma symptoms. "
12/01/2009 - "To evaluate the impact on ARQOL of EFF1009 in adults with asthma. "
02/01/2008 - "The inclusion of the medical food EFF1009 in asthma management regimens can improve patient quality of life and decrease reliance on rescue medication."
12/01/2009 - "A medical food, EFF1009, containing the fatty acids gamma-linolenic acid (GLA) and eicosapentaenoic acid (EPA) decreases leukotriene B(4) synthesis in patients with asthma. "

Related Drugs and Biologics

1.	gamma-Linolenic Acid
2.	Eicosapentaenoic Acid
3.	Leukotriene B4
4.	Fatty Acids (Saturated Fatty Acids)